The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/39053
StudyName: Eligibility Diffuse Large B-Cell Lymphoma NCT01040871
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 24.11.2019
License: Creative Commons BY 4.0

----

Description: 
Study of the Combination of VELCADE, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01040871
